Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Divis Laboratories

Divis Laboratories

BSE: 532488|NSE: DIVISLAB|ISIN: INE361B01024|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Aug 18, 16:00
634.10
-11.4 (-1.77%)
VOLUME 43,976
LIVE
NSE
Aug 18, 15:50
635.20
-10.5 (-1.63%)
VOLUME 325,016
News on Divis Laboratories
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Divi's Lab gets green nod for Rs 100 cr modernisation project

8.30 am | 14 Aug 2017 |  Source: PTI

The company wants to modernise one of the two units by shifting non-production activities to proposed new area and meet all modern production facility...

Divi's Labs Vishakhapatnam plant completes inspection

3.27 pm | 04 Aug 2017 |  Source: PTI

In a regulatory filing to the BSE, Divi's Laboratories said the company's Unit-2 at Vishakhapatnam has been inspected by five inspectors from ...

Hold Divi’s Laboratories; target of Rs 665: ICICI Direct

4.09 pm | 26 Jul 2017 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Divi’s Laboratories with a target price of Rs 665 in its research report dated July 24, 2017....

Divis Labs tanks 6% after dismal Q1 performance, profit falls 41% 

3.04 pm | 24 Jul 2017 |  Source: Moneycontrol.com

Operating profit fell 39.4 percent to Rs 244.82 crore and margin contracted by 990 basis points to 29.8 percent compared with year-ago quarter despite...

Buy HPCL, Divis Labs, SPARC, Capital First, Idea Cellular, Welspun Corp: Gujral 

9.21 am | 20 Jul 2017 |  Source: CNBC-TV18

Ashwani Gujral of ashwanigujral.com recommends buying HPCL, Divis Laboratories, SPARC, Capital First, Idea Cellular and Welspun Corp....

Divis Laboratories' board meeting on July 22, 2017

1.23 pm | 14 Jul 2017 |  Source: Moneycontrol.com

Notice is hereby given that a meeting of Board of Directors of the Company is scheduled to be held on Saturday, the 22nd day of July 2017, inter-alia,...

Hold Divi’s Laboratories; target of Rs 740: ICICI Direct

3.55 pm | 11 Jul 2017 |  Source: Moneycontrol.com

ICICI Direct has recommended Hold rating on Divi’s Laboratories with a target price of Rs 740 in its research report dated July 10, 2017....

Buy Divis Lab, OBC, Supreme Infra, Bharat Financial, Indiabulls Real Estate: Gujral 

9.10 am | 11 Jul 2017 |  Source: CNBC-TV18

Ashwani Gujral of ashwanigujral.com recommends buying Divis Laboratories, Oriental Bank of Commerce, Supreme Infrastructure, Bharat Financial and Indi...

Still analysing root cause of the glitch: Ravi Varanasi, NSE 

4.31 pm | 10 Jul 2017 |  Source: CNBC-TV18

In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, Ravi Varanasi of NSE clarifies about the technical glitch....

USFDA to lift import alert on Visakhapatnam unit: Divi's Labs

2.05 pm | 10 Jul 2017 |  Source: PTI

The company "has been informed by the United States Food and Drug Administration (USFDA) that it will lift the Import Alert 99-32 imposed on the compa...

USFDA to lift ban on Divis Labs' Unit-II at Visakhapatnam

12.27 pm | 10 Jul 2017 |  Source: Moneycontrol.com

Divis Labs has informed that USFDA to lift import alert 99-32 on the company's Unit-II at Visakhapatnam....

Divis Labs zooms 20% as USFDA to lift import alert on unit-II at Visakhapatnam 

12.08 pm | 10 Jul 2017 |  Source: Moneycontrol.com

The US Food and Drug Administration issued an import alert under clauses 99-32 and 66-40 in March of 2017....

Hold Divi’s Laboratories; target of Rs 625: ICICI Direct

4.51 pm | 31 May 2017 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Divi’s Laboratories with a target price of Rs 625 in its research report dated May 29, 2017....

Hold Divi's Laboratories; target of Rs 690: Axis Direct

1.20 pm | 11 Apr 2017 |  Source: Moneycontrol.com

Axis Direct recommended hold rating on Divi's Laboratories with a target price of Rs 690 in its research report dated April 10, 2017....

Top trading ideas by SP Tulsian

9.14 am | 01 Mar 2017 |  Source: CNBC-TV18

In an interview to CNBC-TV18 SP Tulsian, sptulsian.com shared his reading and outlook on the market and also gave recommendations on various stocks....

Hold Divi's Laboratories; target of Rs 740: Axis Direct

3.40 pm | 20 Feb 2017 |  Source: Moneycontrol.com

Axis Direct recommended hold rating on Divi's Laboratories with a target price of Rs 740 in its research report dated February 10, 2017....

1 2 3
Quick Links for Divis Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.